The Europe Water for Injection market is projected to grow from USD 11.4 billion in 2025 to USD 27.49 billion by 2035, expanding at a CAGR of 9.20%, fueled by rising demand in pharmaceutical manufacturing, increasing biologics production, and growing healthcare investments across the region.

Europe Water For Injection Market Statical Scope

Due to rising demand for injectable drugs, vaccines, and biologics. pharmaceutical growth and focus on high-purity water systems are key drivers. Major growth factors include increasing chronic disease, investment in sterile manufacturing, and upgrades of older water systems to make compliance standards.

Technologically, market is shifting from distillation to advanced membrane- based systems like reverse osmosis and ultrafiltration, improving efficiency, sustainability and regulatory compliance.

Europe Water For Injection Market Share, By Application, 2025 (%)

• Formulate Parenteral Drugs-The segment dominated the market with a 61% share, due to high demand for sterile injectables, strict quality standards, and growing biologics and hospital- based intravenous therapies.
• Solvent- The segment accounted for 24% of the total market share, because it is widely required in drug formulation, dilution, and processing steps, ensuring purity, stability, and safe pharmaceutical manufacturing.
• Cleaning Agents- The segment accounted for 15% of the total market share, because it is essential for recruitment cleaning, contamination control, and maintaining GMP-compliant sterile pharmaceutical production environments.

Europe Water For Injection Market Share, By End-User, 2025 (%)

• Pharmaceutical and Biotechnology Companies-The segment dominated the market with a 66.00% share, due to large- a scale injectable drug production, biologics manufacturing, and strict regulatory need for high- purity water systems.
• Research Institutes- The segment accounted for 19.00% of the total market share, because they widely use high-purity water for drug development, laboratory testing, an experimental-studies under strict quality standards.
• Others- The segment accounted for 15.00% of the total market share, due to use in hospitals, contract manufacturing, and small labs requiring purified water for various medical and diagnostic applications.

Top Companies in the Europe Water For Injection Market

• Thermo Fisher Scientific, Inc.
• Merck KGaA
• Eurocrit Labs International
• Evoqua Water Technologies
• Veolia Water Solutions and Technologies
• ICU Medical Inc.
• Danaher Corporation (Cytiva)
• Rocky Mountain Biologicals
• B. Braun Melsungen AG
• SteriCare Solutions
• Veltek Associates, Inc.

Segments Covered in the Report

By Application

• Formulate Parental Drugs
• Solvent
• Cleaning Agents

By End-user

• Pharmaceutical and Biotechnology Companies
• Research Institutes
• Others